Purification and Structural Characterization of a Novel Class of Protein- Based Magnetic Resonance Imaging Contrast Agents

Purification and Structural Characterization of a Novel Class of Protein- Based Magnetic Resonance Imaging Contrast Agents

More than one-third of all Magnetic Resonance Imaging (MRI) scans employ image-enhancing contrast agents to increase the differential signal intensity between diseased and normal tissue. Because current clinical contrast agents exhibit low relaxivity (mM-1 s-1), low dose efficiency, and rapid secret...

Full description

Bibliographic Details
Main Author:	Hubbard, Kendra Lynette
Format:	Others
Published:	Digital Archive @ GSU 2010
Subjects:	Relaxivity Magnetic resonance imaging Contrast agents Gadolinium Circular dichroism Fluorescence resonance energy transfer
Online Access:	http://digitalarchive.gsu.edu/chemistry_theses/33 http://digitalarchive.gsu.edu/cgi/viewcontent.cgi?article=1032&context=chemistry_theses

Similar Items

Optimization of Expression and Purification Methods for the Study of Protein-Based Magnetic Resonance Imaging Contrast Agents
by: White, Natalie
Published: (2011)

Нas the stability of gadoliniumbased magnetic resonance contrast media the clinical significance?
by: V. O. Panov, et al.
Published: (2016-09-01)

Theranostics and contrast agents for magnetic resonance imaging
by: Yohan Jeong, et al.
Published: (2018-07-01)

Research progress of Gd-MOF magnetic resonance contrast agent
by: ZHOU Weixiu, et al.
Published: (2019-12-01)

Magnetic Resonance Imaging Contrast Agents: A Review of Literature
by: Zahra Sahraei, et al.
Published: (2015-10-01)

The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances
by: Xiaodong Li, et al.
Published: (2020-11-01)

Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection
by: Rong Lu, et al.
Published: (2020-12-01)

A New Potential Contrast Agent for Magnetic Resonance Imaging: Iron Oxide-4A Nanocomposite
by: Zareei L., et al.
Published: (2019-04-01)

THE USE OF INNOVATIVE DOMESTIC CONTRAST AGENT GADOLINIUM-BASED FOR MR-CANCER DIAGNOSIS IN EXPERIMENT
by: V. I. Chernov, et al.
Published: (2016-02-01)

Gadolinium Endohedral Metallofullerenes for Future Magnetic Resonance Imaging Contrast Agents
by: Ye, Youqing
Published: (2014)

Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
by: T Mortezazadeh, et al.
Published: (2020-02-01)

Spin resonance excitation of Gd-based contrast agents for thermal energy deposition
by: Dinger, Steven Conrad
Published: (2017)

Toxicity associated with gadolinium-based contrast-enhanced examinations
by: Silvia Maria Lattanzio
Published: (2021-05-01)

A rare case of acute respiratory distress syndrome caused by use of gadolinium‐based magnetic resonance imaging contrast media
by: Yi Lee, et al.
Published: (2019-11-01)

Natural oral contrast agents for gastrointestinal magnetic resonance imaging
by: Mehrnaz Zarrini, et al.
Published: (2015-09-01)

Novel MR imaging contrast agents for cancer detection
by: Daryoush Shahbazi-Gahrouei
Published: (2009-05-01)

A Gadolinium(III) Complex Based on the Thymine Nucleobase with Properties Suitable for Magnetic Resonance Imaging
by: Marta Orts-Arroyo, et al.
Published: (2021-04-01)

Carbonized paramagnetic complexes of Mn (II) as contrast agents for precise magnetic resonance imaging of sub-millimeter-sized orthotopic tumors
by: Chen, H., et al.
Published: (2022)

Carbonized paramagnetic complexes of Mn (II) as contrast agents for precise magnetic resonance imaging of sub-millimeter-sized orthotopic tumors
by: Chen, H., et al.
Published: (2022)

Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
by: Caterina Beatrice Monti, et al.
Published: (2020-04-01)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
by: Atiya Fatima, et al.
Published: (2021-09-01)

Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines
by: Nacif Marcelo S, et al.
Published: (2012-02-01)

MRI Contrast Enhancement using Gd2O3 Nanoparticles
by: Klasson, Anna
Published: (2008)

Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
by: Simona Bussi, et al.
Published: (2020-02-01)

Next Generation Lanthanide-based Contrast Agents for Applications in MRI, Multimodal Imaging, and Anti-cancer Therapies
by: Chaudhary, Richa
Published: (2008)

Next Generation Lanthanide-based Contrast Agents for Applications in MRI, Multimodal Imaging, and Anti-cancer Therapies
by: Chaudhary, Richa
Published: (2008)

Spectroscopic Investigations of the Binding Interaction of a New Indanedione Derivative with Human and Bovine Serum Albumins
by: Mihaela Hillebrand, et al.
Published: (2009-04-01)

Recent progress of rare earth nanoparticles as magnetic resonance imaging contrast agents
by: ZHANG Xiaofen, et al.
Published: (2016-12-01)

MRI with Contrast Enhancement in a Patient with Chronic Kidney Disease: to Contrast Have Not Be Denied. Where Should We Put the Comma?
by: E. S. Kamyshova, et al.
Published: (2019-03-01)

DRESS Syndrome Induced by a Gadolinium-Based Contrast Agent in a 13-Year-Old Boy
by: Campanón-Toro, M.V, et al.
Published: (2022)

Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance
by: Neil Zaki, et al.
Published: (2020-12-01)

Nanoparticle-Based Systems for T1-Weighted Magnetic Resonance Imaging Contrast Agents
by: Dianjun Liu, et al.
Published: (2013-05-01)

Non-Cardiogenic Pulmonary Oedema Following the Use of Gadolinium-Based Contrast Medium: A Case Report
by: Nguyen Chilan, et al.
Published: (2020-08-01)

Targeted Molecular MR Imaging of HER2 and EGFR Using De Novo Designed Protein Contrast Agents
by: Qiao, Jingjuan
Published: (2011)

Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives
by: Bang J. Guo, et al.
Published: (2018-09-01)

The dynamics of extracellular gadolinium-based contrast agent excretion into pleural and pericardial effusions quantified by T1 mapping cardiovascular magnetic resonance
by: Simon Thalén, et al.
Published: (2019-11-01)

The use of an iron or manganese enriched juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography (MRCP)
by: P Prasert, et al.
Published: (2009-06-01)

Current approaches to development of contrast agents for MRI diagnostics
by: K. N. Sorokina, et al.
Published: (2011-12-01)

Aptamer-conjugated magnetic nanoparticles as targeted magnetic resonance imaging contrast agent for breast cancer
by: Mohammad Keshtkar, et al.
Published: (2016-01-01)

Hepatocyte-specific contrast agent-enhanced magnetic resonance cholangiography: perioperative evaluation of the biliary tree
by: Luciana Carmen Zattar-Ramos, et al.
Published: (2017-11-01)